Lars Green

Board member since 2021

Nationality: Danish

Born: 1967

Non-independent

Board committees, LEO Pharma

Chair of the Audit Committee.

Positions and management duties

Board member of the LEO Foundation, LEO Holding, Pharmacosmos, H. Lundbeck (AC Chair), Novo Holdings (Chair) and the Novo Nordisk Foundation. Vice Chair of the Danish Committee on Corporate Governance.

Career

Former CFO & EVP Finance, Investor Relations, IT & Legal at Novozymes (now Novonesis). Previously EVP Business Services & Compliance, SVP Regional CFO North America and Japan as well as SVP Finance at Novo Nordisk.

Special competencies

Extensive international finance leadership experience in pharma and bioindustrial organizations. Led major finance and IT transformation projects, ESG initiatives, financial reporting enhancements, cyber security programs and risk management at Novozymes and Novo Nordisk, with expertise in technology, manufacturing, quality and corporate governance